Literature DB >> 22414337

Early post-operative thrombosis of the prosthetic mitral valve in patient with heparin-induced thrombocytopenia.

Attila Cziráki1, Zénó Ajtay, Agnes Nagy, László Márton, Zsófia Verzár, Sándor Szabados.   

Abstract

Heparin-induced thrombocytopenia (HIT) is one of the most common immune-mediated adverse drug reactions, with frequencies as high as 2-3% for certain groups of post-cardiac surgery patients. We report on an 50-year-old woman with early post-operative thrombosis of the prosthetic mitral valve due to heparin-induced thrombocytopenia. Non-invasive imaging (two-dimensional transesophageal echocardiography; 2D-TEE) allowed the exact localisation of thrombotic masses and revealed the increase of the mean diastolic mitral gradient. The HIT diagnosis was proved by the clinical scoring system, and with the identification of heparin platelet factor 4-induced antibodies. After the withdrawal of LMWH therapy and the start of intravenous lepirudin treatment, the patient's medical condition improved continuously. Follow-up echocardiography showed a step-wise decrease in the severity of the mean diastolic mitral valve gradient and a complete resolution of thrombus formations. Perhaps we may remind ourselves that, whilst HIT is one of the most common immune-mediated adverse drug reactions for certain groups of post-cardiac surgery patients, it can be managed successfully. We would also stress the importance of serial 2D-TEE examinations in the early post-operative period.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22414337      PMCID: PMC3312837          DOI: 10.1186/1749-8090-7-23

Source DB:  PubMed          Journal:  J Cardiothorac Surg        ISSN: 1749-8090            Impact factor:   1.637


  9 in total

1.  Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings.

Authors:  G K Lo; D Juhl; T E Warkentin; C S Sigouin; P Eichler; A Greinacher
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

2.  Recommendations for the practice of echocardiography in infective endocarditis.

Authors:  Gilbert Habib; Luigi Badano; Christophe Tribouilloy; Isidre Vilacosta; Jose Luis Zamorano; Maurizio Galderisi; Jens-Uwe Voigt; Rosa Sicari; Bernard Cosyns; Kevin Fox; Svend Aakhus
Journal:  Eur J Echocardiogr       Date:  2010-03

3.  Impact of the patient population on the risk for heparin-induced thrombocytopenia.

Authors:  T E Warkentin; J A Sheppard; P Horsewood; P J Simpson; J C Moore; J G Kelton
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

4.  Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia.

Authors:  Krystin Krauel; Christian Pötschke; Claudia Weber; Wolfram Kessler; Birgitt Fürll; Till Ittermann; Stefan Maier; Sven Hammerschmidt; Barbara M Bröker; Andreas Greinacher
Journal:  Blood       Date:  2010-10-19       Impact factor: 22.113

Review 5.  Heparin-induced thrombocytopenia.

Authors:  A Greinacher; K Althaus; K Krauel; S Selleng
Journal:  Hamostaseologie       Date:  2010-01       Impact factor: 1.778

Review 6.  Heparin-induced thrombocytopenia and cardiac surgery.

Authors:  Theodore E Warkentin; Andreas Greinacher
Journal:  Ann Thorac Surg       Date:  2003-12       Impact factor: 4.330

7.  Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.

Authors:  Gilbert Habib; Bruno Hoen; Pilar Tornos; Franck Thuny; Bernard Prendergast; Isidre Vilacosta; Philippe Moreillon; Manuel de Jesus Antunes; Ulf Thilen; John Lekakis; Maria Lengyel; Ludwig Müller; Christoph K Naber; Petros Nihoyannopoulos; Anton Moritz; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

8.  Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Theodore E Warkentin; Andreas Greinacher; Andreas Koster; A Michael Lincoff
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

9.  Heparin-induced thrombocytopenia: laboratory studies.

Authors:  J G Kelton; D Sheridan; A Santos; J Smith; K Steeves; C Smith; C Brown; W G Murphy
Journal:  Blood       Date:  1988-09       Impact factor: 22.113

  9 in total
  2 in total

1.  Successful thrombolytic treatment of prosthetic mitral valve thrombosis.

Authors:  Emine Gazi; Burak Altun; Ahmet Temiz; Yucel Colkesen
Journal:  BMJ Case Rep       Date:  2013-06-07

2.  Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy.

Authors:  Zoltan Nemeth; Attila Cziraki; Sandor Szabados; Bernadett Biri; Sandor Keki; Akos Koller
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.